Ver registro no DEDALUS
Exportar registro bibliográfico

Metrics


Metrics:

Bosentan, a mixed endothelin receptor antagonist, inhibits superoxide anion-induced pain and inflammation in mice (2015)

  • Authors:
  • USP affiliated authors: ALVES FILHO, JOSÉ CARLOS FARIAS - FMRP ; CUNHA, FERNANDO DE QUEIROZ - FMRP ; CUNHA, THIAGO MATTAR - FMRP
  • USP Schools: FMRP; FMRP; FMRP
  • DOI: 10.1007/s00210-015-1160-z
  • Subjects: HIPERTENSÃO PULMONAR; ESTRESSE OXIDATIVO; DOR; ENDOTELINAS; ANTI-INFLAMATÓRIOS
  • Language: Inglês
  • Imprenta:
  • Source:
  • Acesso online ao documento

    Online accessDOI or search this record in
    Informações sobre o DOI: 10.1007/s00210-015-1160-z (Fonte: oaDOI API)
    • Este periódico é de assinatura
    • Este artigo NÃO é de acesso aberto
    Versões disponíveis em Acesso Aberto do: 10.1007/s00210-015-1160-z (Fonte: Unpaywall API)

    Título do periódico: Naunyn-Schmiedeberg's Archives of Pharmacology

    ISSN: 0028-1298,1432-1912



      Não possui versão em Acesso aberto
    Informações sobre o Citescore
  • Título: Naunyn-Schmiedeberg's Archives of Pharmacology

    ISSN: 0028-1298

    Citescore - 2017: 2.29

    SJR - 2017: 0.836

    SNIP - 2017: 0.784


  • Exemplares físicos disponíveis nas Bibliotecas da USP
    BibliotecaCód. de barrasNúm. de chamada
    FMRP2748515pcd 2748515 Estantes Deslizantes
    How to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas

    • ABNT

      SERAFIM, Karla G. G.; NAVARRO, Suelen A.; ZARPELON, Ana C.; et al. Bosentan, a mixed endothelin receptor antagonist, inhibits superoxide anion-induced pain and inflammation in mice. Naunyn-Schmiedeberg's Archives of Pharmacology, Heidelberg, v. 388, n. 11, p. 1211-1221, 2015. Disponível em: < http://dx.doi.org/ 10.1007/s00210-015-1160-z > DOI: 10.1007/s00210-015-1160-z.
    • APA

      Serafim, K. G. G., Navarro, S. A., Zarpelon, A. C., Pinho-Ribeiro, F. A., Fattori, V., Cunha, T. M., et al. (2015). Bosentan, a mixed endothelin receptor antagonist, inhibits superoxide anion-induced pain and inflammation in mice. Naunyn-Schmiedeberg's Archives of Pharmacology, 388( 11), 1211-1221. doi:10.1007/s00210-015-1160-z
    • NLM

      Serafim KGG, Navarro SA, Zarpelon AC, Pinho-Ribeiro FA, Fattori V, Cunha TM, Alves Filho JCF, Cunha F de Q, Casagrande R, Verri Júnior WA. Bosentan, a mixed endothelin receptor antagonist, inhibits superoxide anion-induced pain and inflammation in mice [Internet]. Naunyn-Schmiedeberg's Archives of Pharmacology. 2015 ; 388( 11): 1211-1221.Available from: http://dx.doi.org/ 10.1007/s00210-015-1160-z
    • Vancouver

      Serafim KGG, Navarro SA, Zarpelon AC, Pinho-Ribeiro FA, Fattori V, Cunha TM, Alves Filho JCF, Cunha F de Q, Casagrande R, Verri Júnior WA. Bosentan, a mixed endothelin receptor antagonist, inhibits superoxide anion-induced pain and inflammation in mice [Internet]. Naunyn-Schmiedeberg's Archives of Pharmacology. 2015 ; 388( 11): 1211-1221.Available from: http://dx.doi.org/ 10.1007/s00210-015-1160-z

    Referências citadas na obra
    Ankier SI (1974) New hot plate tests to quantify antinociceptive and narcotic antagonist activities. Eur J Pharm 1:1–4. doi: 10.1016/0014-2999(74)90195-2
    Avdeev SN, Tsareva NA, Nekliudova GV, Chuchalin AG (2013) First clinical experience with endothelin receptor antagonist bosentan used in patients with pulmonary hypertension: results of a one-year study. Ter Arkh 85:38–43
    Barton M, Yanagisawa M (2008) Endothelin: 20 years from discovery to therapy. Can J Physiol Pharmacol 86:485–498. doi: 10.1139/Y08-059
    Binshtok AM, Wang H, Zimmermann K, et al (2008) Nociceptors are interleukin-1beta sensors. J Neurosci 28:14062–14073. doi: 10.1523/JNEUROSCI.3795-08.2008
    Bradley JR (2008) TNF-mediated inflammatory disease. J Pathol 214:149–160. doi: 10.1002/path.2287
    Bradley PP, Christensen RD, Rothstein G (1982) Cellular and extracellular myeloperoxidase in pyogenic inflammation. Blood 60:618–622
    Casagrande R, Georgetti SR, Verri Jr WA, et al (2006) Protective effect of topical formulations containing quercetin against UVB-induced oxidative stress in hairless mice. J Photochem Photobiol B 84:21–27. doi: 10.1016/j.jphotobiol.2006.01.006
    Channick R, Badesch DB, Tapson VF, et al (2001) Effects of the dual endothelin receptor antagonist bosentan in patients with pulmonary hypertension: a placebo-controlled study. J Hear Lung Transpl 20:262–263
    Conte Fde P, Barja-Fidalgo C, Verri Jr WA, et al (2008) Endothelins modulate inflammatory reaction in zymosan-induced arthritis: participation of LTB4, TNF-alpha, and CXCL-1. J Leukoc Biol 84:652–660. doi: 10.1189/jlb.1207827
    Cunha TM, Verri WA, Silva JS, et al (2005) A cascade of cytokines mediates mechanical inflammatory hypernociception in mice. Proc Natl Acad Sci U S A 102:1755–1760. doi: 10.1073/pnas.0409225102
    Cunha TM, Verri WA, Vivancos GG, et al (2004) An electronic pressure-meter nociception paw test for mice. Braz J Med Biol Res 37:401–407. doi: 10.1590/S0100-879X2004000300018
    Davar G, Hans G, Fareed MU, et al (1998) Behavioral signs of acute pain produced by application of endothelin-1 to rat sciatic nerve. Neuroreport 9:2279–2283
    De-Melo JD, Tonussi CR, D’Orléans-Juste P, Rae GA (1998) Articular nociception induced by endothelin-1, carrageenan and LPS in naive and previously inflamed knee-joints in the rat: inhibition by endothelin receptor antagonists. Pain 77:261–269
    Donate PB, Cunha TM, Verri Jr WA, et al (2012) Bosentan, an endothelin receptor antagonist, ameliorates collagen-induced arthritis: the role of TNF-alpha in the induction of endothelin system genes. Inflamm Res 61:337–348. doi: 10.1007/s00011-011-0415-5
    Dusting GJ, Selemidis S, Jiang F (2005) Mechanisms for suppressing NADPH oxidase in the vascular wall. Mem Inst Oswaldo Cruz 97–103
    Ferreira SH, Romitelli M, de Nucci G (1989) Endothelin-1 participation in overt and inflammatory pain. J Cardiovasc Pharmacol 13(Suppl 5):S220–S222. doi: 10.1097/00005344-198900135-00065
    Fiore G, Florio P, Micheli L, et al (2005) Endothelin-1 triggers placental oxidative stress pathways: putative role in preeclampsia. J Clin Endocrinol Metab 90:4205–4210. doi: 10.1210/jc.2004-1632
    Fuchs J, Zollner TM, Kaufmann R, Podda M (2001) Redox-modulated pathways in inflammatory skin diseases. Free Radic Biol Med 30:337–353
    Gabriel A, Kuddus RH, Abdul SR, et al (1998) Superoxide-induced changes in endothelin (ET) receptors in hepatic stellate cells. J Hepatol 29:614–627. doi: 10.1016/S0168-8278(98)80157-8
    Gokin AP, Fareed MU, Pan HL, et al (2001) Local injection of endothelin-1 produces pain-like behavior and excitation of nociceptors in rats. J Neurosc 14:5358–5366
    Graido-Gonzalez E, Doherty JC, Bergreen EW, et al (1998) Plasma endothelin-1, cytokine, and prostaglandin E2 levels in sickle cell disease and acute vaso-occlusive sickle crisis. Blood 92:2551–2555
    Guerrero AT, Verri Jr WA, Cunha TM, et al (2008) Involvement of LTB4 in zymosan-induced joint nociception in mice: participation of neutrophils and PGE2. J Leukoc Biol 83:122–130. doi: 10.1189/jlb.0207123
    Hattori H, Subramanian KK, Sakai J, et al (2010) Small-molecule screen identifies reactive oxygen species as key regulators of neutrophil chemotaxis. Proc Natl Acad Sci U S A 107:3546–3551. doi: 10.1073/pnas.0914351107
    Hsu J-H, Oishi P, Wiseman DA, et al (2010) Nitric oxide alterations following acute ductal constriction in the fetal lamb: a role for superoxide. Am J Physiol Lung Cell Mol Physiol 298:L880–L887. doi: 10.1152/ajplung.00384.2009
    Hung VKL, Chen SMY, Tai LW, et al (2012) Over-expression of endothelin-1 in astrocytes, but not endothelial cells, ameliorates inflammatory pain response after formalin injection. Life Sci 618–622
    Hung VKL, Tai LW, Qiu Q, et al (2014) Over-expression of astrocytic ET-1 attenuates neuropathic pain by inhibition of ERK1/2 and Akt(s) via activation of ETA receptor. Mol Cell Neurosci 60:26–35. doi: 10.1016/j.mcn.2014.02.007
    Jandeleit-Dahm KA, Watson AM (2012) The endothelin system and endothelin receptor antagonists. Curr Opin Nephrol Hypertens 21:66–71. doi: 10.1097/MNH.0b013e32834dde48
    Jarvis MF, Wessale JL, Zhu CZ, et al (2000) ABT-627, an endothelin ETA receptor-selective antagonist, attenuates tactile allodynia in a diabetic rat model of neuropathic pain. Eur J Pharmacol 388:29–35. doi: 10.1016/S0014-2999(99)00865-1
    Jewell AN, Swamydas M, Castillo CI, et al (2010) The endothelin axis stimulates the expression of pro-inflammatory cytokines and pro-migratory molecules in breast cancer. Cancer Investig 28:932–943. doi: 10.3109/07357907.2010.496757
    Ji R-R, Kohno T, Moore KA, Woolf CJ (2003) Central sensitization and LTP: do pain and memory share similar mechanisms? Trends Neurosci 26:696–705. doi: 10.1016/j.tins.2003.09.017
    Jin X, Gereau RW (2006) Acute p38-mediated modulation of tetrodotoxin-resistant sodium channels in mouse sensory neurons by tumor necrosis factor-alpha. J Neurosci 26:246–255. doi: 10.1523/JNEUROSCI.3858-05.2006
    Joosten LA, Netea MG, Kim SH, et al (2006) IL-32, a proinflammatory cytokine in rheumatoid arthritis. Proc Natl Acad Sci U S A 103:3298–3303. doi: 10.1073/pnas.0511233103
    Katalinic V, Modun D, Music I, Boban M (2005) Gender differences in antioxidant capacity of rat tissues determined by 2,2′-azinobis (3-ethylbenzothiazoline 6-sulfonate; ABTS) and ferric reducing antioxidant power (FRAP) assays. Comp Biochem Physiol C Toxicol Pharmacol 140:47–52. doi: 10.1016/j.cca.2005.01.005
    Keles S, Halici Z, Atmaca HT, et al (2014) The ocular endothelin system: a novel target for the treatment of endotoxin-induced uveitis with bosentan. Investig Ophthalmol Vis Sci 55:3517–3524. doi: 10.1167/iovs.14-14193
    Khodorova A, Fareed MU, Gokin A, et al (2002) Local injection of a selective endothelin-B receptor agonist inhibits endothelin-1-induced pain-like behavior and excitation of nociceptors in a naloxone-sensitive manner. J Neurosci 22:7788–7796
    Kim YO, Kim IJ, Yoon MH (2015) Antiallodynic effect through spinal endothelin-B receptor antagonism in rat models of complex regional pain syndrome. Neurosci Lett 584:45–49. doi: 10.1016/j.neulet.2014.10.005
    Kress M, Riedl B, Reeh PW (1995) Effects of oxygen radicals on nociceptive afferents in the rat skin in vitro. Pain 62:87–94
    Kvietys PR, Granger DN (2012) Role of reactive oxygen and nitrogen species in the vascular responses to inflammation. Free Radic Biol Med 52:556–592. doi: 10.1016/j.freeradbiomed.2011.11.002
    Lau D, Szöcs K, Klinke A, et al (2014) Myeloperoxidase upregulates endothelin receptor type B expression. J Mol Cell Cardiol 69:76–82. doi: 10.1016/j.yjmcc.2013.12.007
    Letizia C, Boirivant M, De Toma G, et al (1998) Plasma levels of endothelin-1 in patients with Crohn’s disease and ulcerative colitis. Ital J Gastroenterol Hepatol 30:266–269
    Liu JQ, Erbynn EM, Folz RJ (2005) Chronic hypoxia-enhanced murine pulmonary vasoconstriction: role of superoxide and gp91phox. Chest. doi: 10.1378/chest.128.6_suppl.594S
    López-Sepúlveda R, Gómez-Guzmán M, Zarzuelo MJ, et al (2011) Red wine polyphenols prevent endothelial dysfunction induced by endothelin-1 in rat aorta: role of NADPH oxidase. Clin Sci (Lond) 120:321–333. doi: 10.1042/CS20100311
    Lowry OH, Rosebrough NJ, Farr AL, Randall RJ (1951) Protein measurement with the Folin phenol reagent. J Biol Chem 193:265–275
    Maioli NA, Zarpelon AC, Mizokami SS, et al (2015) The superoxide anion donor, potassium superoxide, induces pain and inflammation in mice through production of reactive oxygen species and cyclooxygenase-2. Braz J Med Biol Res. doi: 10.1590/1414-431X20144187
    Martínez-Revelles S, Caracuel L, Márquez-Martín A, et al (2012) Increased endothelin-1 vasoconstriction in mesenteric resistance arteries after superior mesenteric ischaemia-reperfusion. Br J Pharmacol 165:937–950. doi: 10.1111/j.1476-5381.2011.01617.x
    Mascia L, Fedorko L, Stewart DJ, et al (2001) Temporal relationship between endothelin-1 concentrations and cerebral vasospasm in patients with aneurysmal subarachnoid hemorrhage. Stroke 32:1185–1190
    Matsuo J, Oku H, Kanbara Y, et al (2009) Involvement of NADPH oxidase and protein kinase C in endothelin-1-induced superoxide production in retinal microvessels. Exp Eye Res 89:693–699. doi: 10.1016/j.exer.2009.06.012
    Miyasaka N, Hirata Y, Ando K, et al (1992) Increased production of endothelin-1 in patients with inflammatory arthritides. Arthritis Rheum 35:397–400. doi: 10.1002/art.1780350406
    Milligan ED, Sloane EM, Langer SJ, et al (2005) Controlling neuropathic pain by adeno-associated virus driven production of the anti-inflammatory cytokine, interleukin-10. Mol Pain 1:9. doi: 10.1186/1744-8069-1-9
    Morelli S, Ferri C, Di Francesco L, et al (1995) Plasma endothelin-1 levels in patients with systemic sclerosis: influence of pulmonary or systemic arterial hypertension. Ann Rheum Dis 54:730–734. doi: 10.1136/ard.54.9.730
    Morgan MJ, Liu ZG (2011) Crosstalk of reactive oxygen species and NF-kappaB signaling. Cell Res 21:103–115. doi: 10.1038/cr.2010.178
    Motte S, McEntee K, Naeije R (2006) Endothelin receptor antagonists. Pharmacol Ther 110:386–414. doi: 10.1016/j.pharmthera.2005.08.012
    Ndengele MM, Cuzzocrea S, Esposito E, et al (2008) Cyclooxygenases 1 and 2 contribute to peroxynitrite-mediated inflammatory pain hypersensitivity. FASEB J 22:3154–3164. doi: 10.1096/fj.08-108159
    Ohanian J, Forman SP, Katzenberg G, Ohanian V (2012) Endothelin-1 stimulates small artery VCAM-1 expression through p38MAPK-dependent neutral sphingomyelinase. J Vasc Res 49:353–362. doi: 10.1159/000336649
    Piechota A, Polanczyk A, Goraca A (2011) Protective effects of endothelin-A receptor antagonist BQ123 against LPS-induced oxidative stress in lungs. Pharmacol Rep 63:494–500
    Pinho-Ribeiro FA, Borghi SM, Staurengo-Ferrari L, et al (2014) Bosentan, a mixed endothelin receptor antagonist, induces antidepressant-like activity in mice. Neurosci Lett 560:57–61. doi: 10.1016/j.neulet.2013.12.018
    Pinho-Ribeiro FA, Hohmann MSN, Borghi SM, et al (2015) Protective effects of the flavonoid hesperidin methyl chalcone in inflammation and pain in mice: role of TRPV1, oxidative stress, cytokines and NF-κB. Chem Biol Interact 228:88–99. doi: 10.1016/j.cbi.2015.01.011
    Pomonis JD, Rogers SD, Peters CM, et al (2001) Expression and localization of endothelin receptors: implications for the involvement of peripheral glia in nociception. J Neurosci 21:999–1006
    Poole S, Cunha FQ, Selkirk S, et al (1995) Cytokine-mediated inflammatory hyperalgesia limited by interleukin-10. Br J Pharmacol 115:684–688
    Rachid MA, Camargos ERS, Barcellos L, et al (2006) Blockade of endothelin ETA/ETB receptors favors a role for endothelin during acute Trypanosoma cruzi infection in rats. Microbes Infect 8:2113–2119. doi: 10.1016/j.micinf.2006.03.017
    Rancourt M-E, Rodrigue M-E, Agharazii M, et al (2010) Role of oxidative stress in erythropoietin-induced hypertension in uremic rats. Am J Hypertens 23:314–320. doi: 10.1038/ajh.2009.242
    Re R, Pellegrini N, Proteggente A, et al (1999) Antioxidant activity applying an improved ABTS radical cation decolorization assay. Free Radic Biol Med 26:1231–1237
    Romero M, Jimenez R, Sanchez M, et al (2010) Vascular superoxide production by endothelin-1 requires Src non-receptor protein tyrosine kinase and MAPK activation. Atherosclerosis 212:78–85. doi: 10.1016/j.atherosclerosis.2010.04.031
    Rubin LJ, Roux S (2002) Bosentan: a dual endothelin receptor antagonist. Expert Opin Investig Drugs 11:991–1002. doi: 10.1517/13543784.11.7.991
    Sadik CD, Noack B, Schacher B, et al (2012) Cytokine production by leukocytes of Papillon-Lefevre syndrome patients in whole blood cultures. Clin Oral Investig 16:591–597. doi: 10.1007/s00784-011-0532-0
    Scalera F, Dittrich R, Beckmann MW, Beinder E (2002) Effect of endothelin-1 on intracellular glutathione and lipid peroxide availability and on the secretion of vasoactive substances by human umbilical vein endothelial cells. Eur J Clin Investig 32:556–562. doi: 10.1046/j.1365-2362.2002.01040.x
    Ting E, Guerrero AT, Cunha TM, et al (2008) Role of complement C5a in mechanical inflammatory hypernociception: potential use of C5a receptor antagonists to control inflammatory pain. Br J Pharmacol 153:1043–1053. doi: 10.1038/sj.bjp.0707640
    Verri Jr WA, Cunha TM, Ferreira SH, et al (2007) IL-15 mediates antigen-induced neutrophil migration by triggering IL-18 production. Eur J Immunol 37:3373–3380. doi: 10.1002/eji.200737488
    Verri Jr WA, Cunha TM, Magro DA, et al (2009) Targeting endothelin ETA and ETB receptors inhibits antigen-induced neutrophil migration and mechanical hypernociception in mice. Naunyn Schmiedeberg's Arch Pharmacol 379:271–279. doi: 10.1007/s00210-008-0360-1
    Verri Jr WA, Cunha TM, Parada CA, et al (2006a) IL-15 mediates immune inflammatory hypernociception by triggering a sequential release of IFN-gamma, endothelin, and prostaglandin. Proc Natl Acad Sci U S A 103:9721–9725. doi: 10.1073/pnas.0603286103
    Verri Jr WA, Cunha TM, Parada CA, et al (2006b) Hypernociceptive role of cytokines and chemokines: targets for analgesic drug development? Pharmacol Ther 112:116–138. doi: 10.1016/j.pharmthera.2006.04.001
    Verri Jr WA, Guerrero AT, Fukada SY, et al (2008) IL-33 mediates antigen-induced cutaneous and articular hypernociception in mice. Proc Natl Acad Sci U S A 105:2723–2728. doi: 10.1073/pnas.0712116105
    Verri Jr WA, Schivo IR, Cunha TM, et al (2004) Interleukin-18 induces mechanical hypernociception in rats via endothelin acting on ETB receptors in a morphine-sensitive manner. J Pharmacol Exp Ther 310:710–717. doi: 10.1124/jpet.103.063990
    Wang T, Qin L, Liu B, et al (2004a) Role of reactive oxygen species in LPS-induced production of prostaglandin E2 in microglia. J Neurochem 88:939–947
    Wang X, Tong M, Chinta S, et al (2006) Hypoxia-induced reactive oxygen species downregulate ETB receptor-mediated contraction of rat pulmonary arteries. Am J Physiol Lung Cell Mol Physiol 290:L570–L578. doi: 10.1152/ajplung.00262.2005
    Wang ZQ, Porreca F, Cuzzocrea S, et al (2004b) A newly identified role for superoxide in inflammatory pain. J Pharmacol Exp Ther 309:869–878. doi: 10.1124/jpet.103.064154
    Yanagisawa M, Kurihara H, Kimura S, et al (1988) A novel peptide vasoconstrictor, endothelin, is produced by vascular endothelium and modulates smooth muscle Ca2+ channels. J Hypertens Suppl 6:S188–S191
    Yayla M, Halici Z, Unal B, et al (2014) Protective effect of Et-1 receptor antagonist bosentan on paracetamol induced acute liver toxicity in rats. Eur J Pharmacol 726:87–95. doi: 10.1016/j.ejphar.2014.01.022
    Yoon MH, Reriani M, Mario G, et al (2013) Long-term endothelin receptor antagonism attenuates coronary plaque progression in patients with early atherosclerosis. Int J Cardiol. doi: 10.1016/j.ijcard.2012.12.001
    Zarpelon AC, Pinto LG, Cunha TM, et al (2012) Endothelin-1 induces neutrophil recruitment in adaptive inflammation via TNFalpha and CXCL1/CXCR2 in mice. Can J Physiol Pharmacol 90:187–199. doi: 10.1139/y11-116